EAM
CVS icon

Eukles Asset Management’s CVS Health CVS Stock Holding History

Eukles Asset Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-120
Closed -$9.47K – 239
2023
Q4 		$9.47K Hold
120
– – ﹤0.01% 152
2023
Q3 		$8.38K Hold
120
– – ﹤0.01% 157
2023
Q2 		$8.3K Hold
120
– – ﹤0.01% 153
2023
Q1 		$8.92K Hold
120
– – ﹤0.01% 144
2022
Q4 		$11K Hold
120
– – 0.01% 138
2022
Q3 		$11K Hold
120
– – 0.01% 135
2022
Q2 		$11K Hold
120
– – 0.01% 132
2022
Q1 		$12K Hold
120
– – 0.01% 135
2021
Q4 		$12K Hold
120
– – 0.01% 138
2021
Q3 		$10K Hold
120
– – 0.01% 141
2021
Q2 		$10K Hold
120
– – 0.01% 169
2021
Q1 		$9K Buy
+120
New +$8.74K 0.01% 136

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Eukles Asset Management's CVS Position: Q1 2024 in Review

Eukles Asset Management sold out of CVS Health (CVS) in Q1 2024, closing a stake of 120 shares — an estimated $9.47K sold.

Eukles Asset Management first reported a position in CVS in Q1 2021 and held it in 12 quarters. The position peaked at $12K in Q1 2022. 2,176 funds tracked by Wall St. Rank hold CVS as of Q1 2024.

  • Eukles Asset Management reported no remaining CVS Health position as of Q1 2024 after selling out during the quarter.
  • Eukles Asset Management sold 120 CVS Health shares in Q1 2024, an estimated $9.47K.
  • Eukles Asset Management first reported a position in CVS Health in Q1 2021 and held it in 12 quarters.
  • Eukles Asset Management's CVS Health position peaked at $12K in Q1 2022.
  • 2,176 funds tracked by Wall St. Rank held CVS Health as of Q1 2024.

Based on Eukles Asset Management's 13F filing for Q1 2024, filed 13 May 2024.